Camille Robert has extensive experience in pharmacology and research, beginning as a PhD student at the Institut de Pharmacologie et de Biologie Structurale from September 2014 to January 2020, focusing on the evaluation of an anti-inflammatory compound in a Francisella tularensis infection model. Following this, Camille served as Scientist I at Evotec, leading pre-clinical evaluations of anti-infective compounds, and subsequently joined SNIPR Biome as a Senior Scientist, specializing in in vivo pharmacology for microbiome-related therapies. Currently, Camille is an Associate Director of Pharmacology at ALK, with a background that includes experience at Y-mAbs Therapeutics and an internship at Sanofi, emphasizing skills in high throughput screening and microbiology research. Education includes a PhD in Pharmacology - Immunology, a Diplôme d'ingénieur in Biochemistry, and ongoing master's degrees focused on Clinical and Industrial Drug Development at the University of Copenhagen.
Location
Copenhagen, Denmark